Nichols William Garrett's Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Mar 20, 2025
- Accession no.
- 0000950170-25-042728
- Filed
- Mar 20, 2025
- Trade date
- Mar 18, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $397.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols William GarrettCIK 0001618364 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | Common Stock | MOption exerciseAcquired | +4,584 | $3.75 | +$17,190 | 83,904 | Direct | |
| Mar 18, 2025 | Common Stock | MOption exerciseAcquired | +13,905 | $1.29 | +$17,937.45 | 97,809 | Direct | |
| Mar 18, 2025 | Common Stock | SSaleDisposed | −45,316 | $8.76 | −$396,968.16 | 52,493 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | Common Stock | MOption exerciseDisposed | −4,584 | $0.00 | $0 | 195,416 | Direct | |
| Mar 18, 2025 | Common Stock | MOption exerciseDisposed | −13,905 | $0.00 | $0 | 31,095 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.